These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14726811)

  • 1. Direct-to-consumer genetic testing: access and marketing.
    McCabe LL; McCabe ER
    Genet Med; 2004; 6(1):58-9. PubMed ID: 14726811
    [No Abstract]   [Full Text] [Related]  

  • 2. ACMG statement on direct-to-consumer genetic testing.
    American College of Medicine Genetics Board of Directors
    Genet Med; 2004; 6(1):60. PubMed ID: 14726812
    [No Abstract]   [Full Text] [Related]  

  • 3. Direct-to-consumer genetics and health policy: a worst-case scenario?
    Caulfield T
    Am J Bioeth; 2009; 9(6-7):48-50. PubMed ID: 19998115
    [No Abstract]   [Full Text] [Related]  

  • 4. CCMG statement on direct-to-consumer genetic testing.
    ; Nelson TN; Armstrong L; Richer J; Evans J; Lauzon J; McGillivray B; Bruyere H; Dougan S
    Clin Genet; 2012 Jan; 81(1):1-3. PubMed ID: 21943145
    [No Abstract]   [Full Text] [Related]  

  • 5. Personal genome testing: do you know what you are buying?
    Howard HC; Borry P
    Am J Bioeth; 2009; 9(6-7):11-3. PubMed ID: 19998102
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetics and managed care: Policy statement of the American College of Medical Genetics.
    Williams MS
    Genet Med; 2001; 3(6):430-5. PubMed ID: 11715009
    [No Abstract]   [Full Text] [Related]  

  • 7. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.
    Robson ME; Storm CD; Weitzel J; Wollins DS; Offit K;
    J Clin Oncol; 2010 Feb; 28(5):893-901. PubMed ID: 20065170
    [No Abstract]   [Full Text] [Related]  

  • 8. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy and ambiguity in counseling patients about genetic risk.
    Lloyd FJ; Reyna VF; Whalen P
    Arch Intern Med; 2001 Nov; 161(20):2411-3. PubMed ID: 11700153
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic testing.
    Boylan M
    Camb Q Healthc Ethics; 2002; 11(3):246-56. PubMed ID: 12082905
    [No Abstract]   [Full Text] [Related]  

  • 11. Direct to confusion: lessons learned from marketing BRCA testing.
    Matloff E; Caplan A
    Am J Bioeth; 2008 Jun; 8(6):5-8. PubMed ID: 18726769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovation, risk, and patient empowerment: the FDA-mandated withdrawal of 23andMe's Personal Genome Service.
    Downing NS; Ross JS
    JAMA; 2014 Feb; 311(8):793-4. PubMed ID: 24474248
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetics and public health.
    American Public Health Association
    Am J Public Health; 1988 Feb; 78(2):209-11. PubMed ID: 11644298
    [No Abstract]   [Full Text] [Related]  

  • 14. Direct marketing of cystic fibrosis carrier screening: commercial push or population need?
    Cuckle H; Lilford R; Wilson J; Sehmi I
    J Med Genet; 1995 Sep; 32(9):758. PubMed ID: 8544204
    [No Abstract]   [Full Text] [Related]  

  • 15. Legal and regulatory issues surrounding carrier testing.
    Charo RA
    Clin Obstet Gynecol; 1993 Sep; 36(3):568-97. PubMed ID: 8403605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.
    J Clin Oncol; 1996 May; 14(5):1730-6; discussion 1737-40. PubMed ID: 8622094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Disjointed" approach to rare diseases is still failing patients, warn MPs.
    O'Dowd A
    BMJ; 2017 Feb; 356():j1037. PubMed ID: 28242776
    [No Abstract]   [Full Text] [Related]  

  • 18. General practitioner attitudes to direct-to-consumer genetic testing in New Zealand.
    Ram S; Russell B; Gubb M; Taylor R; Butler C; Khan I; Shelling A
    N Z Med J; 2012 Oct; 125(1364):14-26. PubMed ID: 23242394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic counseling versus genetic self testing: what challenges?].
    Englert Y
    Rev Med Brux; 2001 Sep; 22(4):A244-6. PubMed ID: 11680182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct-to-consumer marketing of genetic tests for cancer: buyer beware.
    Gray S; Olopade OI
    J Clin Oncol; 2003 Sep; 21(17):3191-3. PubMed ID: 12874271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.